We are very pleased to announce that the Salje Group has received funding from Lyme Disease UK (LDUK) and the Lyme Resource Centre (LRC) to investigate the cell biology of Borrelia burgdorferi sensu stricto, B. garinii and B. afzelii, the bacteria that cause Lyme disease.
Dr Jeanne Salje said: “Lyme disease can have a devastating impact on patients, yet there are still major gaps in our understanding of the fundamental biology of the bacteria that cause it. Our laboratory has extensive experience studying other tick-borne bacterial pathogens, and this funding from Lyme Disease UK and the Lyme Resource Centre gives us an exciting opportunity to apply that expertise to Borrelia, the bacterium responsible for Lyme disease. By investigating how these bacteria grow, divide and interact with their environment, we hope to uncover new aspects of their biology that could ultimately inform better approaches to diagnosis and treatment.”
Dr Salje will use her group’s expertise on vector-borne bacteria to establish a dedicated UK research programme focused on the cell biology of Borrelia. She will apply knowledge gained from her extensive research on the genomics, bacterial physiology, infection cycle and mechanisms of disease of Orientia tsutsugamushi, the bacteria responsible for scrub typhus (a life-threatening disease endemic throughout Asia).
Borrelia burgdorferi
This new study will include the application of modern approaches and advanced imaging techniques to investigate how Borrelia fundamentally differ, grow, remodel their cell walls, interact with host tissues, adapt during infection, and cause inflammatory disease. Experimental systems will be designed to study Borrelia in association with both tick and mammalian cells, and build a strong scientific evidence base and internationally recognised expertise here in the UK. The goal is to provide the essential foundational knowledge required to attract more funding and create a long-term research programme to help design more effective interventions and drive innovation in diagnostics, vaccines and new treatments.